TEVETEN PLUS 600mg / 12.5mg tablets medication leaflet

C09DA02 eprosartan + hydrochlorothiazide • Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics

Eprosartan and hydrochlorothiazide are a combination of medications used to treat high blood pressure. Eprosartan works by relaxing blood vessels, while hydrochlorothiazide is a diuretic that helps eliminate excess water and salt from the body.

The combination is administered orally as tablets, once daily, according to the doctor's instructions. The dose is adjusted depending on the patient's response to treatment and any side effects.

Side effects may include dizziness, fatigue, digestive disorders, low potassium levels, or, rarely, allergic reactions. Monitoring blood pressure and electrolytes is recommended throughout the treatment.

The combination of eprosartan and hydrochlorothiazide is effective for controlling blood pressure, especially in patients who do not respond adequately to monotherapy.

General data about TEVETEN PLUS 600mg / 12.5mg

Substance: eprosartan + hydrochlorothiazide

Date of last drug list: 01-07-2013

Commercial code: W43497002

Concentration: 600mg / 12.5mg

Pharmaceutical form: tablets

Quantity: 28

Product type: original

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Other substances similar to eprosartan + hydrochlorothiazide